| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/06/2026 | ±4.9% | -14.3% | under-priced |
| 05/07/2026 | ±4.7% | +10.6% | under-priced |
| 11/05/2025 | ±3.0% | -9.4% | under-priced |
| 08/05/2025 | ±2.7% | +16.4% | under-priced |
| 05/07/2025 | ±3.2% | +0.0% | over-priced |
| 11/08/2024 | ±2.6% | +28.7% | under-priced |
| 08/07/2024 | ±3.7% | +18.4% | under-priced |
| 05/07/2024 | ±2.1% | -4.5% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $0.36 | $904M | $29M |
| Q1 FY2026 | $2.05 | $807M | $169M |
| Q4 FY2025 | $0.03 | $797M | $3M |
| Q3 FY2025 | $-0.03 | $711M | $-2M |
Axon Enterprise, Inc. Common Stock (AXON) reports in 79 days, with the next report estimated for 11/30/2026. Across the last 8 reports, options priced an average ±3.4% earnings move while the stock actually moved 12.8% on average — the market has tended to under-price AXON's earnings risk. Fundamentals into the print: EPS down 18.2% year-over-year, revenue up 35.3%. QuantLogix's live 5-factor engine currently reads AXON as a neutral at 51/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →